Notice for spesolimab (Boehringer Ingelheim Pty Ltd)
Active ingredients
spesolimab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for infusion
Indication
Treatment of generalised pustular psoriasis
Therapeutic area
Dermatology